COMMUNIQUÉS West-GlobeNewswire

OraSure Technologies Supports World AIDS Day With Innovative Programs to Enable HIV Testing
30/11/2017
BETHLEHEM, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced several new HIV testing-related [...]
Industry Veteran Dr. Meqsood Rehman Promoted to Chief Executive Officer of Gala Global Inc.
30/11/2017
ORANGE COUNTY, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Gala Global, Inc. (OTCBB: GLAG ) today announced that it has promoted Dr. Meqsood Rehman, 41, to the Chief Executive Officer of Gala Global, Inc., taking over [...]
SeaSpine Announces FDA 510(k) Clearance of OsteoBallast™ Demineralized Bone Matrix in Resorbable Mesh
30/11/2017
CARLSBAD, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE ), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced [...]
Ultragenyx to Highlight Pipeline at Analyst and Investor Day on December 4
30/11/2017
NOVATO, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, announced [...]
Targovax ASA: New member of the board of directors
30/11/2017
Oslo, Norway, 30 November 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that the extraordinary general meeting of Targovax [...]
Celldex Therapeutics Initiates Phase 1 Study of New Product Candidate CDX-1140 in Solid Tumors
30/11/2017
HAMPTON, N.J., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq: CLDX ) announced today that enrollment has opened in its open-label, Phase 1 study of CDX-1140 in patients with advanced solid tumors [...]
Achaogen to Participate in the Guggenheim Securities 5th Annual Boston Healthcare Conference
30/11/2017
SOUTH SAN FRANCISCO, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram- [...]
Cancer Genetics to Participate in Upcoming Investor Conferences
30/11/2017
RUTHERFORD, N.J., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX ), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced that the [...]
BIOLIFE4D Selects FischTank Marketing and PR as Agency of Record
30/11/2017
CHICAGO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- BIOLIFE4D , a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has retained FischTank Marketing and [...]
Hooper Holmes Inc. to Present at the LD Micro 10th Annual Main Event on December 5, 2017
30/11/2017
OLATHE, Kan., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Hooper Holmes, Inc. (OTCQX:HPHW) today announced that, Henry Dubois, Chief Executive Officer, and Mark Clermont, President, will be featured presenters at the LD Micro 10 [...]
Portola Pharmaceuticals to Present New Data on Betrixaban, Andexanet Alfa and Cerdulatinib at the 59th American Society of Hematology (ASH) Annual Meeting
30/11/2017
SOUTH SAN FRANCISCO, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA ) today announced that new data on the Company’s first FDA-approved anticoagulant, betrixaban, and its two [...]
HempAmericana Inc. Executes Lease for High-Capacity CBD Oil Production Facility Site in Maine; Two-year Lease on Massive 17k Sq Ft Permit-Ready Facility Commences December 1
30/11/2017
NEW YORK, Nov. 30, 2017 (GLOBE NEWSWIRE) -- HempAmericana, Inc. (OTC:HMPQ) (the “Company”) is excited to announce that the Company has fully executed the lease for a 17,000-square foot state-of-the-art facility in [...]
Final Patient Completes Treatment in Innovation Pharmaceuticals Phase 2b Study of Oral Prurisol for Psoriasis
30/11/2017
BEVERLY, Mass., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals Inc., (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announces that the last patient has completed study [...]
New Publication Summarizes Phase 1 Studies of CK-2127107 Showing Tolerability and Amplification of Skeletal Muscle Response to Nerve Activation
30/11/2017
Next Generation Fast Skeletal Muscle Activator Appears Promising Compared to Tirasemtiv in Studies of Healthy Volunteers SOUTH SAN FRANCISCO, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq [...]
Cesca Therapeutics Inc. to Participate in the LD Micro 10th Annual Main Event on Thursday, December 7, 2017
30/11/2017
RANCHO CORDOVA, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ: KOOL ) a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today [...]
New Publication Shows Respiratory Decline Correlated With Disease Progression in People Living With ALS
30/11/2017
Retrospective Analyses of Clinical Trials in ALS Shows Faster Rate of Decline in Slow Vital Capacity Strongly Predicts Increased Risk of Future Clinical Events SOUTH SAN FRANCISCO, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE [...]
Industry Veteran Dr. Maqsood Rehman Promoted to Chief Executive Officer of Gala Global Inc.; Company Strengthens Senior Management Team as it Repositions Company’s Growth Strategy
30/11/2017
ANAHEIM, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Gala Global, Inc. (OTC Pink:GLAG) today announced that it has promoted Dr. Maqsood Rehman, to the Chief Executive Officer of Gala Global, Inc., taking over from Timothy [...]
Sunesis Pharmaceuticals Appoints William Quinn as Chief Financial Officer and Senior Vice President, Finance and Corporate Development
30/11/2017
SOUTH SAN FRANCISCO, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced the appointment of William Quinn as Chief Financial Officer and Senior Vice President, Finance [...]
Tonix Pharmaceuticals to Present at 10th Annual LD Micro Investor Conference
30/11/2017
NEW YORK, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix), a company in Phase 3 development of Tonmya®* (cyclobenzaprine HCI sublingual tablets), or TNX-102 SL, a U.S. Food [...]

Pages